The biotech sector in 2026 is offering one of the most dynamic investment landscapes we’ve seen in years. With scientific breakthroughs, regulatory changes, and technological convergence all aligning, this is a moment where strategic investors can capture outsized value. Below are the key forces to understand—and how they translate into actionable opportunities. 1. The Technology...Read More

AI isn’t just improving—it’s accelerating. A few key measures: According to the Stanford Institute for Human‑Centered Artificial Intelligence’s AI Index 2025, key benchmarks like MMLU (multitask language understanding) and GPQA (general purpose question answering) have improved dramatically in the last year. For example,  inference cost at the level of GPT-3.5 dropped from around $20 per...Read More